Ratings by BMO Capital (Connor Murphy)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/7/2026 | Trevi Therapeutics | TRVI | Maintain | Outperform (N/A) |
|
Details | ||
| 7/20/2026 | Trevi Therapeutics | TRVI | New Coverage | Outperform (N/A) |
19.07 (11.88) |
-37.7% | Details |
